C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men

Ridker, Paul M, Paynter, Nina P., Rifai, Nader, Gaziano, J. Michael, Cook, Nancy R.·2008·Circulation
DOI 10.1161/circulationaha.108.814251

Cited by (840)

Items 101–200 of 840

  1. Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection
    Chris Todd Longenecker, Ying Jiang, Carl E. Orringer, Robert Gilkeson, Sara A. Debanne, Nicholas Funderburg, Michael M. Lederman, Norma J. Storer, Danielle E. Labbato, Grace A. McComsey · 2013 · AIDS
  2. Optimizing Statin Treatment for Primary Prevention of Coronary Artery Disease
    Rodney A. Hayward, Harlan M. Krumholz, Donna M. Zulman, Justin W. Timbie, Sandeep S. Vijan · 2010 · Annals of Internal Medicine
  3. Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a UK tri-ethnic prospective cohort study (SABRE—Southall And Brent REvisited)
    Tillin, Therese, Hughes, Alun D, Whincup, Peter, Mayet, Jamil, Sattar, Naveed, McKeigue, Paul M, Chaturvedi, Nish, On behalf of the SABRE Study Group · 2014 · Heart
  4. Circulating microRNAs predict future fatal myocardial infarction in healthy individuals – The HUNT study
    Anja Bye, Helge Rørvik Røsjø, Javaid Nauman, Gustavo José Justo da Silva, Turid Follestad, Torbjørn Omland, Ulrik Wisløff · 2016 · Journal of Molecular and Cellular Cardiology
  5. Expanding the Role of Nurses to Improve Hypertension Care and Control Globally
    Cheryl Dennison Himmelfarb, Yvonne Y Commodore-Mensah, Martha N. Hill · 2016 · Annals of Global Health
  6. National lipid association annual summary of clinical lipidology 2016
    Bays, Harold E., Jones, Peter H., Orringer, Carl E., Brown, W. Virgil, Jacobson, Terry A. · 2016 · Journal of Clinical Lipidology
  7. Influence of disease activity on the physical activity of rheumatoid arthritis patients
    Vanesa Hernández-Hernández, Iván Ferraz‐Amaro, Federico Díaz‐González · 2013 · Lara D. Veeken
  8. Genome-wide Association and Population Genetic Analysis of C-Reactive Protein in African American and Hispanic American Women
    Alex P. Reiner, Sandra S. Beleza, Nora Franceschini, Paul Livermore Auer, Jennifer G. Robinson, Charles L Kooperberg, Ulrike Peters, Hua Tang · 2012 · The American Journal of Human Genetics
  9. Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms
    Elke Arts, Călin D. Popa, Alfons A den Broeder, Rogier Donders, Aamer Sandoo, Tracey E. Toms, Silvia Rollefstad, Eirik Ikdahl, Anne Grete Semb, George D. Kitas et al. · 2015 · Annals of the Rheumatic Diseases
  10. Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure
    Raimund M. Erbel, Matthew Jay Budoff · 2012 · European Heart Journal
  11. Prognostic value of cardiovascular biomarkers in the population
    Neumann, Johannes Tobias, Twerenbold, Raphael, Weimann, Jessica, Ballantyne, Christie M., Benjamin, Emelia J., Costanzo, Simona, de Lemos, James A., deFilippi, Christopher R., Di Castelnuovo, Augusto, Donfrancesco, Chiara et al. · 2024 · JAMA
  12. Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study
    Suthesh Sivapalaratnam, S. Matthijs Boekholdt, Mieke D. Trip, Manjinder S. Sandhu, Robert Luben, John J.P. Kastelein, Nicholas J. Wareham, Kay‐Tee Khaw · 2010 · Heart
  13. Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality
    Christina M. Parrinello, Pamela L. Lutsey, Christie Mitchell Ballantyne, Aaron R. Folsom, James S. Pankow, Elizabeth Selvin · 2015 · American Heart Journal
  14. Three Reasons to Abandon Low-Density Lipoprotein Targets
    Rodney A. Hayward, Harlan M. Krumholz · 2012 · Circulation Cardiovascular Quality and Outcomes
  15. C-Reactive Protein: Clinical and Epidemiological Perspectives
    Salazar, Juan, Martínez, María Sofía, Chávez, Mervin, Toledo, Alexandra, Añez, Roberto, Torres, Yaquelín, Apruzzese, Vanessa, Silva, Carlos, Rojas, Joselyn, Bermúdez, Valmore · 2014 · Cardiology Research and Practice
  16. Adapting machine learning techniques to censored time-to-event health record data: A general-purpose approach using inverse probability of censoring weighting
    David M. Vock, Julian A. Wolfson, Sunayan Bandyopadhyay, Gediminas Adomavičius, Paul E. Johnson, Gabriela Vazquez‐Benitez, Patrick J. O’Connor · 2016 · Journal of Biomedical Informatics
  17. Screening for Future Cardiovascular Disease Using Age Alone Compared with Multiple Risk Factors and Age
    Nicholas Wald, Mark C. Simmonds, Joan K. Morris · 2011 · PLoS ONE
  18. Multimarker Prediction of Coronary Heart Disease Risk
    Hyeon Chang Kim, Philip Greenland, Jacques E. Rossouw, JoAnn Elisabeth Manson, Barbara B. Cochrane, Norman L. Lasser, Marian C. Limacher, Donald M. Lloyd‐Jones, Karen L. Margolis, Jennifer G. Robinson · 2010 · Journal of the American College of Cardiology
  19. Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis
    Bruce E. Sands, Pam R. Taub, Alessandro Armuzzi, Gary S. Friedman, Michele Moscariello, Nervin Lawendy, Ronald D. Pedersen, Gary L. Chan, Chudy I. Nduaka, Daniel M. Quirk et al. · 2019 · Clinical Gastroenterology and Hepatology
  20. Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective
    RICHARD J. KONES · 2010 · Drug Design Development and Therapy
  21. Cardiovascular Risk Prediction Models and Scores in the Era of Personalized Medicine
    Areti Sofogianni, Nikolaos Stalikas, Christina Antza, Κωνσταντίνος Τζιόμαλος · 2022 · Journal of Personalized Medicine
  22. Inflammatory markers in coronary heart disease
    Mohammad Madjid, James T. Willerson · 2011 · British Medical Bulletin
  23. C1q/TNF-related protein-1: an adipokine marking and promoting atherosclerosis
    Lu Lin, Ruiyan Zhang, Xiao Qun Wang, Zhu Hui Liu, Ying H. Shen, Feng Hua Ding, Hua Meng, Ling Jie Wang, Xiao Xiang Yan, Ke Yang et al. · 2015 · European Heart Journal
  24. Statins and inflammation: an update
    Petter Quist‐Paulsen · 2010 · Current Opinion in Cardiology
  25. Lipoprotein(a): more interesting than ever after 50 years
    Dubé, Joseph B., Boffa, Michael B., Hegele, Robert A., Koschinsky, Marlys L. · 2012 · Current Opinion in Lipidology
  26. 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures
    Donald E. Casey, Randal J. Thomas, Vivek Bhalla, Yvonne Y Commodore-Mensah, Paul A. Heidenreich, Dhaval Sanjeev Kolte, Paul Muntner, Sidney C. Smith, John A. Spertus, John R. Windle et al. · 2019 · Circulation Cardiovascular Quality and Outcomes
  27. Problems With Risk Reclassification Methods for Evaluating Prediction Models
    Margaret Sullivan Pepe · 2011 · American Journal of Epidemiology
  28. C-reactive protein: Risk factor, biomarker and/or therapeutic target?
    Jacques J. Genest · 2010 · Canadian Journal of Cardiology
  29. The Clinical Utility of High-Sensitivity C-Reactive Protein in Cardiovascular Disease and the Potential Implication of JUPITER on Current Practice Guidelines
    Samia Mora, Kiran Musunuru, Roger Scott Blumenthal · 2008 · Clinical Chemistry
  30. Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings
    Katarzyna Dziopa, Folkert Wouter Asselbergs, Jasmine Gratton, Nish Chaturvedi, Amand Floriaan Schmidt · 2022 · Diabetologia
  31. Systematic Review on the Role of IL-6 and IL-1β in Cardiovascular Diseases
    Nurlubek Katkenov, Zhussipbek Mukhatayev, Samat Kozhakhmetov, Aliya Sailybayeva, Makhabbat S. Bekbossynova, Almagul R. Kushugulova · 2024 · Journal of Cardiovascular Development and Disease
  32. Cardiovascular risk scores do not account for the effect of treatment: a review
    Su May Liew, Jenny A Doust, Paul Glasziou · 2011 · Heart
  33. Clinical prediction models for mortality and functional outcome following ischemic stroke: A systematic review and meta-analysis
    Marion Fahey, Elise Crayton, Charles D.A. Wolfe, Abdel Douiri · 2018 · PLoS ONE
  34. Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies
    Setor Kwadzo Kunutsor, Stephan J. L. Bakker, Richard William James, Robin P. F. Dullaart · 2015 · Atherosclerosis
  35. Personalized medicine—a modern approach for the diagnosis and management of hypertension
    Carmine Savoia, Massimo Volpe, Guido Grassi, Claudio Borghi, Enrico Agabiti Rosei, Rhian M. Touyz · 2017 · Clinical Science
  36. Age-related trends in lipid levels: a large-scale cross-sectional study of the general Chinese population
    Lei Feng, Shiyan Nian, Zongwu Tong, Ying Yan Zhu, Ying Li, Chun‐Ting Zhang, Xuejing Bai, Xuan Luo, Mengna Wu, Zefeng Yan · 2020 · BMJ Open
  37. Exercise intervention and inflammatory markers in coronary artery disease: A meta-analysis
    Swardfager, Walter, Herrmann, Nathan, Cornish, Stephen, Mazereeuw, Graham, Marzolini, Susan, Sham, Lauren, Lanctôt, Krista L. · 2012 · American Heart Journal
  38. Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor α and interleukin‐6) in the long‐term followup of patients with giant cell arteritis
    Ana García‐Martínez, José Hernández‐Rodríguez, Georgina Espígol‐Frigolé, Sergio Prieto‐González, Montserrat Butjosa, Marta Segarra, Ester Lozano, Maria Cinta Cid · 2010 · Arthritis Care & Research
  39. High-sensitivity C-reactive protein as a biomarker of risk in coronary artery disease
    Doroteia Silva, António Pais de Lacerda · 2012 · Revista Portuguesa de Cardiologia (English Edition)
  40. Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events
    Thomas Berend Sehestedt, Stig Lyngbæk, Jesper Eugen‐Olsen, Jørgen Jeppesen, Ove Andersen, Tine W. Hansen, Allan R Linneberg, Torben Jørgensen, Steen B. Haugaard, Michael Hecht Olsen · 2011 · Atherosclerosis
  41. The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus
    Helena Enocsson, Jesper Karlsson, Haiyun Li, Yi Wu, Irving Kushner, Jonas Wetterö, Christopher Sjöwall · 2021 · Journal of Clinical Medicine
  42. Implications of Increased C-Reactive Protein for Cardiovascular Risk Stratification in Black and White Men and Women in the US
    Mary Cushman, Leslie Ain McClure, Virginia J. Howard, Nancy S. Jenny, Susan C. Gilchrist, George Howard · 2009 · Clinical Chemistry
  43. Practical use of the Framingham risk score in primary prevention: Canadian perspective.
    N. John Bosomworth · 2011 · Europe PMC (PubMed Central)
  44. Using Internally Developed Risk Models to Assess Heterogeneity in Treatment Effects in Clinical Trials
    James Francis Burke, Rodney A. Hayward, Jason Nelson, David M. Kent · 2014 · Circulation Cardiovascular Quality and Outcomes
  45. Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance
    Nazanin Aghel, Diego Delgado, Jeffrey Howard Lipton · 2017 · Vascular Health and Risk Management
  46. Genetic Cardiovascular Risk Prediction
    George Thanassoulis, Ramachandran Srini Vasan · 2010 · Circulation
  47. Data mining for censored time-to-event data: a Bayesian network model for predicting cardiovascular risk from electronic health record data
    Sunayan Bandyopadhyay, Julian A. Wolfson, David M. Vock, Gabriela Vazquez‐Benitez, Gediminas Adomavičius, Mohamed Elidrisi, Paul E. Johnson, Patrick J. O’Connor · 2014 · Data Mining and Knowledge Discovery
  48. Consensus statement on management of dyslipidemia in Indian subjects
    K. Sarat Chandra, Manish Bansal, Tiny Nair, Shamanna Seshadri Iyengar, Rajeev Gupta, Subhash Chand Manchanda, Padinhare Purayil Mohanan, V. Dayasagar Rao, C.N. Manjunath, J.P.S. Sawhney et al. · 2014 · Indian Heart Journal
  49. Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management
    Michelle L. Griffith, Bipin N. Savani, Jeffrey B. Boord · 2010 · Blood
  50. National Lipid Association Annual Summary of Clinical Lipidology 2015
    Harold Edward Bays, Peter H. Jones, William Virgil Brown, Terry A. Jacobson · 2014 · Journal of clinical lipidology
  51. Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study
    Ioanna Tzoulaki, Konstantinos C. Siontis, John P. A. Ioannidis · 2011 · BMJ
  52. Risk prediction in cardiovascular disease: The prognostic significance of endothelial dysfunction
    Billie‐Jean Martin, Todd J. Anderson · 2009 · Canadian Journal of Cardiology
  53. Management of Cardiovascular Risk: The Importance of Meeting Lipid Targets
    Antonio M. Gotto, Jennifer E. Moon · 2012 · The American Journal of Cardiology
  54. The Evolution and Refinement of Traditional Risk Factors for Cardiovascular Disease
    Emil M. deGoma, Joshua W. Knowles, Fabio Angeli, Matthew Jay Budoff, Daniel James Rader · 2011 · Cardiology in Review
  55. Sleep heart rate variability assists the automatic prediction of long-term cardiovascular outcomes
    Lulu Zhang, Huili Wu, Xiangyu Zhang, Xinfa Wei, Fengzhen Hou, Yan Ma · 2019 · Sleep Medicine
  56. Beyond Coronary Calcification, Family History, and C-Reactive Protein
    Purav S. Mody, Parag H. Joshi, Amit Khera, Colby R. Ayers, Anand K. Rohatgi · 2016 · Journal of the American College of Cardiology
  57. Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment
    Paul Muntner, Paul Kieran Whelton · 2017 · Journal of the American College of Cardiology
  58. Intraindividual variability of C-reactive protein: The Multi-Ethnic Study of Atherosclerosis
    Emil M. deGoma, Benjamin C. French, Richard L. Dunbar, Matthew Allison, Emile R. Mohler, Matthew Jay Budoff · 2012 · Atherosclerosis
  59. Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: The FRESCO Study
    Jaume Marrugat, Isaac Subirana, Rafel Ramos, Joan Vila, Alejandro Marín-Ibáñez, María Jesús Guembe, Fernando Rigo, María José Tormo Díaz, Conchi Moreno‐Iribas, Joan Josep Cabré et al. · 2014 · Preventive Medicine
  60. Proteína C reativa de alta sensibilidade como biomarcador de risco na doença coronária
    Doroteia Silva, António Pais de Lacerda · 2012 · Revista Portuguesa de Cardiologia
  61. Brief Report: The Ability of the 2013 American College of Cardiology/American Heart Association Cardiovascular Risk Score to Identify Rheumatoid Arthritis Patients With High Coronary Artery Calcification Scores
    Vivian K. Kawai, Cecilia P. Chung, Joseph F. Solus, Annette M. Oeser, Paolo Raggi, C. Michael Stein · 2014 · Arthritis & Rheumatology
  62. Inflammation‐induced foam cell formation in chronic inflammatory disease
    Thomas A. Angelovich, Anna C. Hearps, Anthony Jaworowski · 2015 · Immunology and Cell Biology
  63. Serum Alkaline Phosphatase and Risk of Incident Cardiovascular Disease: Interrelationship with High Sensitivity C-Reactive Protein
    Setor Kwadzo Kunutsor, Stephan J. L. Bakker, Jenny E. Kootstra‐Ros, Ronald T. Gansevoort, John Gregson, Robin P. F. Dullaart · 2015 · PLoS ONE
  64. Erectile Dysfunction Is a Hallmark of Cardiovascular Disease: Unavoidable Matter of Fact or Opportunity to Improve Men’s Health?
    Dimitri Yannas, Francesca Frizza, Linda Vignozzi, Giovanni Corona, Mario Maggi, Giulia Rastrelli · 2021 · Journal of Clinical Medicine
  65. Cardiovascular risk assessment - From individual risk prediction to estimation of global risk and change in risk in the population
    John A. Batsis, Francisco Alejandro López-Jiménez · 2010 · BMC Medicine
  66. Identifying novel biomarkers for cardiovascular disease risk prediction
    Yin Ge, Thomas J. Wang · 2012 · Journal of Internal Medicine
  67. The Association of Framingham and Reynolds Risk Scores With Incidence and Progression of Coronary Artery Calcification in MESA (Multi-Ethnic Study of Atherosclerosis)
    Andrew Paul DeFilippis, Michael Joseph Blaha, Chiadi E. Ndumele, Matthew Jay Budoff, Donald M. Lloyd‐Jones, Robyn L. McClelland, Susan C. Gilchrist, Mary Cushman, Nathan D. Wong, Roger Scott Blumenthal et al. · 2011 · Journal of the American College of Cardiology
  68. Use of reclassification for assessment of improved prediction: an empirical evaluation
    Tzoulaki, Ioanna, Liberopoulos, George, Ioannidis, John P A · 2011 · International Journal of Epidemiology
  69. I Diretriz Brasileira de Hipercolesterolemia Familiar (HF)
    RD Santos, ACM Gagliardi, Hermes Tóros Xavier, A Casella Filho, DB Araújo, FY Cesena, RJ Alves, AC Pereira, AMP Lotemberg, APM Chacra et al. · 2012 · Arquivos Brasileiros de Cardiologia
  70. Ankle–brachial index and cardiovascular risk prediction: An analysis of 11,594 individuals with 10-year follow-up
    Timothy P. Murphy, Rajoo Dhangana, Michael J. Pencina, Ralph B. D’Agostino · 2011 · Atherosclerosis
  71. C-Reactive Protein and Coronary Heart Disease: Predictive Test or Therapeutic Target?
    Aroon Dinesh Hingorani, Tina Shah, Juan Pablo Casas, Steve Eric Humphries, Philippa J. Talmud · 2008 · Clinical Chemistry
  72. Minimal and Null Predictive Effects for the Most Popular Blood Biomarkers of Cardiovascular Disease
    John P. A. Ioannidis, Ioanna Tzoulaki · 2012 · Circulation Research
  73. C-Reactive Protein and Coronary Heart Disease: All Said—Is Not It?
    Frederik Strang, Heribert Schunkert · 2014 · Mediators of Inflammation
  74. Cardiovascular risk and atherosclerosis prevention
    Jiri J Frohlich, Ahmad J Al-Sarraf · 2012 · Cardiovascular Pathology
  75. Risk Estimates for Atherosclerotic Cardiovascular Disease in Adults With Congenital Heart Disease
    George K. Lui, Ian S. Rogers, Victoria Y. Ding, Haley Hedlin, Kirstie MacMillen Lechich, David Joel Maron, Christy Sillman, Anitra Romfh, Tara C. Dade, Christiane L. Haeffele et al. · 2016 · The American Journal of Cardiology
  76. Assessment of Cardiovascular Disease Risk in South Asian Populations
    Sultana Monira Hussain, Brian F. Oldenburg, Yuanyuan Wang, Sophia Zoungas, Andrew Maxwell Tonkin · 2013 · International Journal of Vascular Medicine
  77. Review of Clinical Practice Guidelines for the Management of LDL-Related Risk
    Pamela Bowe Morris, Christie Mitchell Ballantyne, Kim K. Birtcher, Steven P. Dunn, Elaine M. Urbina · 2014 · Journal of the American College of Cardiology
  78. C-reactive protein improves risk prediction in patients with acute coronary syndromes
    François Schiele, N. Meneveau, Marie‐France Seronde, Romain Chopard, Vincent Descotes‐Genon, Joanna Dutheil, Jean‐Pierre Bassand, on behalf of the 'Reseau de Cardiologie de Franche Comte' · 2009 · European Heart Journal
  79. Circulating gamma glutamyltransferase and prediction of cardiovascular disease
    Setor Kwadzo Kunutsor, Stephan J. L. Bakker, Jenny E. Kootstra‐Ros, Ronald T. Gansevoort, Robin P. F. Dullaart · 2014 · Atherosclerosis
  80. Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative
    Sheldon W. Tobe, James A. Stone, Melissa C. Brouwers, Onil K. Bhattacharyya, Kimberly M. Walker, Martin G. Dawes, Jacques J. Genest, Steven A. Grover, Gord J. Gubitz, David C.W. Lau et al. · 2011 · Canadian Medical Association Journal
  81. Effects of rose hip intake on risk markers of type 2 diabetes and cardiovascular disease: a randomized, double-blind, cross-over investigation in obese persons
    U Andersson, Karin Berger, A Högberg, Mona Landin‐Olsson, Cecilia Holm · 2011 · European Journal of Clinical Nutrition
  82. Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV‐positive individuals
    Clare L V Westhorpe, Anna Maisa, Tim D. Spelman, Jennifer Hoy, Elizabeth M. Dewar, Sofie Karapanagiotidis, Anna C. Hearps, Wan‐Jung Cheng, Janine M. Trevillyan, Sharon R. Lewin et al. · 2013 · Immunology and Cell Biology
  83. Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection
    Kim Robin van Daalen, Dudan Zhang, Stephen K. Kaptoge, Ellie Paige, Emanuele Di Angelantonio, Lisa A M Pennells · 2024 · The Lancet Global Health
  84. Biomarkers of cardiovascular disease risk in women
    JoAnn Elisabeth Manson, Shari S. Bassuk · 2014 · Metabolism
  85. Cardiovascular risk
    Rupert Payne · 2012 · British Journal of Clinical Pharmacology
  86. Classical and Novel Biomarkers for Cardiovascular Risk Prediction in the United States
    Aaron R. Folsom · 2013 · Journal of Epidemiology
  87. Rosuvastatin for Primary Prevention Among Individuals With Elevated High-Sensitivity C-Reactive Protein and 5% to 10% and 10% to 20% 10-Year Risk
    Paul M. Ridker, Jean G. MacFadyen, Børge Grønne Nordestgaard, Wolfgang Köenig, John J.P. Kastelein, Jacques J. Genest, Robert J. Glynn · 2010 · Circulation Cardiovascular Quality and Outcomes
  88. Predictive Utility of Cardiovascular Risk Prediction Algorithms in Inflammatory Rheumatic Diseases: A Systematic Review
    Keith Colaco, Vanessa Ocampo, Ana Patricia Ayala, Paula Harvey, Dafna D. Gladman, Vincent Piguet, Lihi Eder · 2019 · The Journal of Rheumatology
  89. Cost-Effectiveness of Using High-Sensitivity C-Reactive Protein to Identify Intermediate- and Low-Cardiovascular-Risk Individuals for Statin Therapy
    Keane K. Lee, Lauren E. Cipriano, Douglas K Owens, Alan S. Go, Mark Andrew Hlatky · 2010 · Circulation
  90. Red Blood Cell Fatty Acid Patterns and Acute Coronary Syndrome
    Gregory C. Shearer, James V. Pottala, John A. Spertus, William Stephen Harris · 2009 · PLoS ONE
  91. Novel Protein Glycan–Derived Markers of Systemic Inflammation and C-Reactive Protein in Relation to Glycemia, Insulin Resistance, and Insulin Secretion
    Carlos Lorenzo, Andreas Festa, Anthony J. Hanley, Marian Rewers, Agustín Escalante, Steven M. Haffner · 2016 · Diabetes Care
  92. Associations of Accelerometer‐Measured Sedentary Time and Physical Activity With Prospectively Assessed Cardiometabolic Risk Factors: The CARDIA Study
    Kara M. Whitaker, Kelley Pettee Gabriel, Matthew Paul Buman, Mark A. Pereira, David R. Jacobs, Jared P. Reis, Bethany Barone Gibbs, Mercedes R. Carnethon, JOHN W. STAUDENMAYER, Stephen Sidney et al. · 2019 · Journal of the American Heart Association
  93. Systematic Coronary Risk Evaluation (SCORE)
    Ian M Graham, Emanuele Di Angelantonio, Frank L.J. Visseren, Dirk De Bacquer, Brian A. Ference, Adam Timmis, Martin Halle, Panos E. Vardas, Radu Huculeci, Marie Therese Cooney · 2021 · Journal of the American College of Cardiology
  94. Dyslipidemia Prevalence, Treatment, Control, and Awareness in the Canadian Health Measures Survey
    Michel Joffres, Margot E. Shields, Mark Stephen Tremblay, Sarah Connor Gorber · 2013 · Canadian Journal of Public Health
  95. Artificial intelligence framework for predictive cardiovascular and stroke risk assessment models: A narrative review of integrated approaches using carotid ultrasound
    Ankush D. Jamthikar, Deep Gupta, Luca Saba, Narendra Nath Khanna, Klaudija Višković, Sophie I. Mavrogeni, John R. Laird, Naveed A. Sattar, Amer M. Johri, Gyan Pareek et al. · 2020 · Computers in Biology and Medicine
  96. Inverse linear associations between liver aminotransferases and incident cardiovascular disease risk: The PREVEND study
    Setor Kwadzo Kunutsor, Stephan J. L. Bakker, Jenny E. Kootstra‐Ros, Hans Blokzijl, Ronald T. Gansevoort, Robin P. F. Dullaart · 2015 · Atherosclerosis
  97. Atherosclerosis in systemic lupus erythematosus
    Sara Cameira Croca, Anisur Rahman · 2017 · Best Practice & Research Clinical Rheumatology
  98. Cardiovascular Disease Prediction by Machine Learning Algorithms Based on Cytokines in Kazakhs of China
    Yunxing Jiang, Xianghui Zhang, Rulin Ma, Xinping Wang, Jiaming Liu, Mulatibieke Keerman, Yizhong Yan, Jiaolong Ma, Yanpeng Song, Jingyu Zhang et al. · 2021 · Clinical Epidemiology
  99. Generalizability of Cardiovascular Disease Clinical Prediction Models: 158 Independent External Validations of 104 Unique Models
    Gaurav Gulati, Jenica Upshaw, Benjamin S. Wessler, Riley J. Brazil, Jason Nelson, David V. Klaveren, Christine M. Lundquist, Jinny G. Park, Hannah McGinnes, Ewout Willem Steyerberg et al. · 2022 · Circulation Cardiovascular Quality and Outcomes
  100. Measures to Summarize and Compare the Predictive Capacity of Markers
    Wen Gu, MARGARET SULLIVAN PEPE · 2009 · The International Journal of Biostatistics